Latest News

P9 Biomarker Panel to Predict Hepatocellular Cancer Risk in Cirrhosis Patients

A recent study published in the BMJ Gut unveiled a novel biomarker…

Risk profile tool provides clearer insight on hospitalized COVID-19 patients who benefit most from baricitinib treatment

A post-hoc analysis of ACTT-2 (Adaptive COVID-19 Treatment Trial-2)…

Race, racism, and COVID-19 in the US: Lessons to be learned

In a publication in The BMJ, Keisha Bentley-Edwards at Duke University,…

UK cancer treatment falls behind other countries, research finds

People in the UK have been treated with chemotherapy and radiotherapy…
Facebook Comments